Progressive Weight Loss and Metabolic Health



Status:Active, not recruiting
Conditions:Obesity Weight Loss, Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:21 - 65
Updated:4/21/2016
Start Date:February 2011
End Date:July 2016

Use our guide to learn which trials are right for you!

This study will evaluate the potential beneficial cardiometabolic effect of moderate (5%)
weight loss and progressive (5%, 10%, and 15%) weight loss in obese adults without diabetes.
Participants will be randomly assigned to one of 2 groups. Group 1: supervised weight loss
group (low-calorie diet). Group 2: supervised weight maintenance group (normal diet). Of
those assigned to group 1, half of the participants will lose 5% of their body weight and
the other half will lose 5%, 10%, and 15% of their weight over time under the guidance of a
dietitian. Research testing will be repeated at each time point (5%, 10%, and 15% weight
loss). In group 2, research testing will be repeated after six months.


Inclusion Criteria:

- Obese: Body Mass Index from 30 to 45

- Insulin Resistant: HOMA-IR score greater than or equal to 2

Exclusion Criteria:

- diabetes

- smoking

- pregnancy

- breastfeeding

- heart failure

- history of liver disease including hepatitis

- alcoholism

- exercise more than 2 hours per week
We found this trial at
1
site
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials